Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study
Maria Frantzi(Academy of Athens), Nicholas P. Anagnou(National and Kapodistrian University of Athens), Axel S. Merseburger(Universitäres Kinderwunschzentrum Lübeck), Dan Theodorescu(University of Arizona), Antonia Vlahou(Academy of Athens), Konstantinos Stravodimos(Laiko General Hospital of Athens), Korbinian Brand(Medizinische Hochschule Hannover), Núria Malats(Spanish National Cancer Research Centre), Ellen C. Zwarthoff(Erasmus MC), William Mullen(University of Glasgow), Ralph Lichtinghagen(Medizinische Hochschule Hannover), Harald Mischak(Mosaiques Diagnostics and Therapeutics (Germany)), Maria G. Roubelakis(National and Kapodistrian University of Athens), Manousos Makridakis(Academy of Athens), Mirari Márquez(Spanish National Cancer Research Centre), Kim E. van Kessel(Erasmus MC), Marta Rava(Instituto de Salud Carlos III), Ioannis Katafigiotis(Laiko General Hospital of Athens), Elena Critselis(Academy of Athens), Jérôme Zoidakis(Academy of Athens), Martin Pejchinοvski(Mosaiques Diagnostics and Therapeutics (Germany)), Mohammed Dakna(Mosaiques Diagnostics and Therapeutics (Germany))
Cited by 104
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
|Journal of Clinical Investigation|1996|800
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Advances in bladder cancer biology and therapy
|Nature reviews. Cancer|2020|783